Abstract
On the basis of the occurrence of antibodies against cytomegalovirus, the incidence of this infection in Europe and North America is about 60–70% of the total population. CMV infections are, in most cases, clinically inapparent. Alterations in the immunological defence system, caused for example by pregnancy, the presence of malignant disease, immunosuppressive or cytostatic therapy, as well as by massive transfusions of blood, are the commonest causes of an increased incidence of CMV infection, combined with a high rate of clinically overt illness (Fig. 1). This applies both to primary CMV infections as well as to the reactivation of latent virus in the body.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Condie RM, Hall BL, Howard RJ, Fry D, Simmons RL, Najarian JS. Treatment of life-threatening infections in renal transplant recipients with high-dose intravenous human IgG. Transplant Proc II 1979; 1: 66–8.
Nicholls AJ, Brown CB, Edwar N, Cuthbertson B, Yap PL, McClelland DBL. Hyperimmune immunoglobulin for cytomegalovirus infections. Lancet 1983;i:532–3.
O’Reilly RJ, Riech L, Gold J, et al. A randomized trial of intravenous hyperimmune globulin for the prevention of cytomegalovirus (CMV) infections following marrow transplantation: Preliminary results. IX. Intern Congress of the Transplant Society, Brighton 1982 (abstract).
Winston DJ, Pollard RB, Ho WG, et al. Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intern Med 1982; 97: 11–8.
Stephan W. Undegraded human immunoglobulin for intravenous use. Vox Sang 1975; 28: 422–37.
Stephan W, Dichtelmiiller H. Beta-propiolacton als sterilisierendes Agens bei der Herstellung eines inträvenosen Immunoglobulin-Präparates. Arzneim Forsch/Drug Res 1983; 33: 1230–1.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Schweitzer, R. (1984). Characterization of the New Cytomygalovirus Immunoglobulin Preparation for Intravenous Use. In: Smit Sibinga, C.T., Das, P.C., Opelz, G. (eds) Transplantation and Blood Transfusion. Developments in Hematology and Immunology, vol 10. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3840-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3840-6_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3842-0
Online ISBN: 978-1-4613-3840-6
eBook Packages: Springer Book Archive